BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Do C, Ford B, Lee DY, Tan C, Escobar P, Wagner B. Gadolinium-based contrast agents: Stimulators of myeloid-induced renal fibrosis and major metabolic disruptors. Toxicol Appl Pharmacol 2019;375:32-45. [PMID: 31082427 DOI: 10.1016/j.taap.2019.05.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Kalantari K, Swaminathan S. Use of Gadolinium in Individuals with Reduced Kidney Function. Clin J Am Soc Nephrol 2021;16:304-6. [PMID: 33431379 DOI: 10.2215/CJN.13950820] [Reference Citation Analysis]
2 Zeng Y, Li H, Li Z, Luo Q, Zhu H, Gu Z, Zhang H, Gong Q, Luo K. Engineered gadolinium-based nanomaterials as cancer imaging agents. Applied Materials Today 2020;20:100686. [DOI: 10.1016/j.apmt.2020.100686] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
3 Sousa NR, Rocha S, Santos-Silva A, Coimbra S, Valente MJ. Cellular and molecular pathways underlying the nephrotoxicity of gadolinium. Toxicol Sci 2021:kfab148. [PMID: 34878122 DOI: 10.1093/toxsci/kfab148] [Reference Citation Analysis]
4 Bruno F, DeAguero J, Do C, Lee DY, Tan C, Escobar GP, Wagner B. Overlapping roles of NADPH oxidase 4 for diabetic and gadolinium-based contrast agent-induced systemic fibrosis. Am J Physiol Renal Physiol 2021;320:F617-27. [PMID: 33615889 DOI: 10.1152/ajprenal.00456.2020] [Reference Citation Analysis]
5 Supawat B, Moungthong P, Chanloi C, Jindachai N, Tima S, Kothan S, Udomtanakunchai C, Tungjai M. Effects of gadolinium-based magnetic resonance imaging contrast media on red blood cells and K562 cancer cells. J Trace Elem Med Biol 2020;62:126640. [PMID: 32932175 DOI: 10.1016/j.jtemb.2020.126640] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Do C, DeAguero J, Brearley A, Trejo X, Howard T, Escobar GP, Wagner B. Gadolinium-Based Contrast Agent Use, Their Safety, and Practice Evolution. Kidney360 2020;1:561-8. [PMID: 34423308 DOI: 10.34067/kid.0000272019] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]